ChronicMyeloidLeukemia相关论文
...
Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase re
Objective Long term tyrosine kinase inhibitors(TKIs)therapy may impact organ function and result in poor treatment outco......
...
L1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid le
Chronic myeloid leukemia (CML) is a clonal disease from hematopoietic stem cells.Surviving leukemia st em cells (LSCs) a......
Objective Somatic mutations of SF3B1 gene have recently been identified in hematopoietic malignancies.The frequency and ......
Imatinib is the standard first line treatment for chronic myeloid leukemia (CML). Owing to doserelated toxicities of Ima......
...
P190BCR-ABL Chronic Myeloid Leukemia Following a Course of S-1 Plus Oxaliplatin Therapy for Advanced
...
AIM Curcumin (Cur) a natural phenolic compound, is the major component of turmeric.To improve the its bioavailabilit......
Hypermethylation of SFRP1 promoter is associated with disease progression in chronic myeloid leukemi
...
...
慢性粒细胞白血病(CML)具有特异性的细胞遗传学改变，形成的BCR-ABL融合基因表达相对分子质量为210 kD的蛋白P210。随着分子生物学等......
【摘要】 目的 观察HA方案 (三尖杉酯碱和阿糖胞苷)联合α-2b干扰素治疗慢性粒细胞白血病的可行性及安全性。方法 将本院自2005年1......
Chronic myeloid leukemia (CML) is characterized by the accumulation of active BCR-ABL protein.Imatinib is the first-line......
本研究旨在探讨螺旋酶抗原基因(HAGE)在急性髓系白血病(AML)和慢性髓系白血病(CML)中的表达状况和临床意义.应用实时定量PCR(RQ-PC......
掌握特殊临床表现为首发症状的慢性粒细胞白血病(CML)特点,有利于减少误诊的发生;应用血细胞分离技术清除循环血液中过度增多的粒......
